FindTrial
Sign In

Can educating parents or caregivers improve the health and medication routine of children with nephrotic syndrome?

Impact of Caregiver Empowerment Module on the Quality of Life and Medication Adherence in the Children with Idiopathic Nephrotic Syndrome - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087380
Enrollment
112
Registered
2025-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality

Interventions

Intervention1: Caregiver Empowerment Module: A structured educational intervention (Caregiver Empowerment Module) delivered in four sessions over 2 months for caregivers of children with nephrotic syn

Sponsors

Jyoti shukla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with SSNS including Frequently Relapsing Nephrotic Syndrome (FRNS), Infrequent Relapsing Nephrotic syndrome (IFRNS), Steroid Dependence Nephrotic Syndrome (SDNS) and their primary caregivers those who can understand hindi or english language

Exclusion criteria

Exclusion criteria: Children with Steroid resistant Nephrotic Syndrome (SRNS), congenital Nephrotic syndrome, Secondary Nephrotic syndrome and their caregivers

Design outcomes

Primary

MeasureTime frame
1. Change in quality of life of children with idiopathic nephrotic syndrome (INS), measured using a pediatric quality of life questionnaire. 2. Change in medication adherence in children with idiopathic Nephrotic Syndrome, assessed using Morisky Medication Adherence ScaleTimepoint: 3 months and 6 months after completion of Caregiver Empowerment Module—

Secondary

MeasureTime frame
Change in the knowledge and practice scores of the caregivers of the children with nephrotic syndromeTimepoint: 3 months and 6 months after completion of Caregiver Empowerment module;correlation between medication adherence and Quality of Life in children with nephrotic syndromeTimepoint: 3 months and 6 months after completion of Caregiver Empowerment module;Association of quality of life and medication adherence with selected demographic and clinical variables.Timepoint: 3 months and 6 months after completion of the Caregiver Empowerment Module;Time to first relapse after enrollment during the study period.Timepoint: continously monitored for 6 months following completion of caregiver Empowerment Module;Time of initiation of Prednisolone therapy at 60 mg/m /day following relapse during study periodTimepoint: continously monitored for 6 months following completion of caregiver Empowerment Module—

Countries

India

Contacts

Public ContactDrAnita Gupta

LHMC and KSCH

drabhijeetsaha@yahoo.com9711007064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026